文献速递母胎医学产科

胎儿异常时外显子测序可澄清预后:一项未被充分认识的应用

When Fetal Anomalies Lead to Prognostic Clarification: An Underrecognized Application of Exome Sequencing.
PubMed 文献 · Prenat Diagn · 2026-08-16

该研究回顾2017至2025年本中心1692例因结构或生化异常行胎儿外显子测序的病例,291例(17%)获得分子诊断,其中5例(约2%)预后相对良好,外显子测序澄清了预后并减少严重综合征可能,有助于更清晰的遗传咨询。

要点

  • 胎儿外显子测序除检出严重疾病外,也可识别预后较轻或可管理的疾病。
  • 1692例中291例(17%)获分子诊断,其中5例(约2%)预后相对良好。
  • 明确分子诊断可减少预后不确定性并支持产前决策。

核心结论

  • 外显子测序不仅能检测严重疾病,还可区分轻度或可管理疾病与复杂综合征,在部分病例中提供有意义的预后安抚并减少不确定性。

研究设计与样本

  • 回顾性分析本中心2017至2025年因结构或生化异常行胎儿外显子测序的全部病例,共1692例胎儿。

主要发现

  • 1692例胎儿中291例(17%)获得分子诊断。
  • 291例中5例(约2%)预后相对良好,包括GLI1变异所致孤立性轴后多指、STS所致X连锁鱼鳞病伴雌三醇低、孤立性内脏反位、CFAP52相关全内脏反位及MAGED2相关暂时性产前Bartter综合征。
  • 上述病例中外显子测序均澄清了预后并降低了严重综合征的可能性。

临床怎么用

  • 对产前结构或生化异常且遗传咨询需求明确的病例,可考虑外显子测序以辅助预后判断。
  • 当检测提示轻度、孤立、暂时性或可治疗表型时,应结合预期出生后结局进行咨询。

局限性

  • 本研究为单中心回顾性分析,预后良好病例仅5例(约2%),结论外推需谨慎。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: To describe a cohort of fetuses with abnormal prenatal findings in whom exome sequencing (ES) identified genetic diagnoses that refined prognostic assessment and reduced prognostic uncertainty. METHODS: We retrospectively reviewed all fetal ES studies performed at our center between 2017 and 2025 for structural or biochemical abnormalities. Cases with a definitive molecular diagnosis were identified, and those with predicted mild, isolated, transient, or treatable phenotypes were classified as having comparatively favorable prognostic implications. Clinical findings and expected postnatal outcomes were analyzed. RESULTS: Among 1692 fetuses undergoing ES, a molecular diagnosis was identified in 291 (17%). Of these, five cases (∼2%) were considered reassuring: isolated postaxial polydactyly due to a GLI1 variant; X-linked ichthyosis (STS) in a fetus with low estriol; isolated situs inversus; CFAP52-related situs inversus totalis; and MAGED2-associated transient antenatal Bartter syndrome. In all cases, ES refined prognosis and reduced the likelihood of severe syndromic conditions, enabling clearer counseling. CONCLUSIONS: Beyond detecting severe disorders, ES may help distinguish mild or manageable conditions from complex syndromes. In selected cases, it provides meaningful reassurance, reduces uncertainty, and supports informed prenatal decision-making.

来源:Prenat Diagn,查看原文。版权归原作者所有。

引用

  1. Rips J, Mor-Shaked H, Birnbaum R, et al. When Fetal Anomalies Lead to Prognostic Clarification: An Underrecognized Application of Exome Sequencing. Prenat Diagn. 2026. PMID: 42604848. doi:10.1002/pd.70239

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。